Drug interactions
Betaxolol + Indacaterol-glycopyrronium
Severity: Major
Betaxolol and Indacaterol-glycopyrronium: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Beta-blockers antagonize the bronchodilating effect of indacaterol and may provoke bronchospasm in patients with obstructive airway disease. Betaxolol is cardioselective, which lowers but does not remove this risk, and this applies to oral betaxolol or ophthalmic use with systemic absorption.
What this interaction means in plain words
Betaxolol and Indacaterol-glycopyrronium can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Betaxolol belongs to Cardiovascular; Indacaterol-glycopyrronium belongs to Respiratory.
Why it happens
Pharmacodynamic antagonism at beta-2 adrenoceptors, with loss of cardioselectivity at higher doses.
What to do
Avoid if possible; if a beta-blocker is required, use the lowest effective dose of a cardioselective agent and monitor lung function and symptoms. Watch for reduced bronchodilator response.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Betaxolol and Indacaterol-glycopyrronium, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Other interactions of Betaxolol
- Acebutolol + Betaxolol Major
- Aldesleukin + Betaxolol Major
- Amifostine + Betaxolol Major
- Amiodarone + Betaxolol Major
- Atenolol-chlorthalidone + Betaxolol Major
- Atenolol + Betaxolol Major
Frequently asked questions
Can I take Betaxolol with Indacaterol-glycopyrronium?
MediHelp rates the interaction as major. Betaxolol and Indacaterol-glycopyrronium can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Beta-blockers antagonize the bronchodilating effect of indacaterol and may provoke bronchospasm in patients with obstructive airway disease. Betaxolol is cardioselective, which lowers but does not remove this risk, and this applies to oral betaxolol or ophthalmic use with systemic absorption.
How serious is the interaction between Betaxolol and Indacaterol-glycopyrronium?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible; if a beta-blocker is required, use the lowest effective dose of a cardioselective agent and monitor lung function and symptoms. Watch for reduced bronchodilator response.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
